KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to $296.6 million.

  • Gsk's Change in Taxes fell 5030.44% to $296.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 2347.69%. This contributed to the annual value of $1.5 billion for FY2025, which is 11809.77% up from last year.
  • Latest data reveals that Gsk reported Change in Taxes of $296.6 million as of Q4 2025, which was down 5030.44% from $420.9 million recorded in Q3 2025.
  • Gsk's Change in Taxes' 5-year high stood at $642.9 million during Q4 2023, with a 5-year trough of -$95.0 million in Q2 2021.
  • Over the past 5 years, Gsk's median Change in Taxes value was $323.5 million (recorded in 2023), while the average stood at $295.9 million.
  • As far as peak fluctuations go, Gsk's Change in Taxes tumbled by 13808.21% in 2021, and later skyrocketed by 3249458.74% in 2025.
  • Gsk's Change in Taxes (Quarter) stood at -$62.0 million in 2021, then soared by 994.71% to $554.8 million in 2022, then rose by 15.88% to $642.9 million in 2023, then fell by 7.17% to $596.8 million in 2024, then crashed by 50.3% to $296.6 million in 2025.
  • Its Change in Taxes stands at $296.6 million for Q4 2025, versus $420.9 million for Q3 2025 and $321.5 million for Q2 2025.